サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1751196

薬局の市場規模、シェア、動向分析レポート：製品タイプ別、地域別、セグメント予測、2025年～2030年

Pharmacy Market Size, Share & Trends Analysis Report By Product (Prescription, OTC), By Type (Hospital Pharmacy, Retail Pharmacy (Chain, Independent, Others), ePharmacy, Others), By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 142 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.35円
薬局の市場規模、シェア、動向分析レポート：製品タイプ別、地域別、セグメント予測、2025年～2030年
出版日: 2025年05月09日
発行: Grand View Research
ページ情報: 英文 142 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

薬局市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の薬局市場規模は2030年までに2兆600億米ドルに達し、予測期間中にCAGR 7.3％で拡大すると予測されています。

慢性疾患の有病率の上昇、オンライン薬局サービスの市場浸透の増加、世界小売企業の同市場への参入が主に成長を促進しています。

主要市場参入企業による各地域でのプレゼンス向上への投資の増加、企業間の提携、利便性とコスト削減を提供するオンライン薬局サービスの採用増加などが、同市場のさらなる成長を促進すると予測されます。OTC医薬品の需要増につながる事故発生率の増加や、主に診断技術や画像技術の向上による医療用医薬品分野の成長は、予測期間中に大きな成長機会を生み出す可能性が高いです。

プロセスやサービス提供の強化のための先端技術の開発、薬局業界参入企業向けに開発された様々なソフトウェアソリューションの利用可能性、ePharmacyサービスの成長を促進するスマートフォン端末の普及も、この市場の発展に寄与しています。主要企業間のコラボレーション、オンライン薬局のデジタルフットプリントの拡大、世界なプレゼンス強化に注力する多くの市場参入企業もこの市場に影響を与えています。

薬局市場のレポートハイライト

  • 製品別では、がん、糖尿病、心血管疾患などの慢性疾患の増加により、処方箋分野が世界の薬局業界を支配し、2024年の売上シェアの80%以上を占めました。
  • OTCセグメントは予測期間中最も急成長すると予測されています。
  • 小売薬局分野は、複数の世界小売企業の薬局事業への参入、主要企業が運営する小売薬局店舗の広大なネットワーク、オンライン小売薬局の成長により、薬局業界で最大の収益シェアを占めました。
  • e薬局セグメントは予測期間中に最も速い成長を経験すると予測されています。
  • 北米は、2024年に50％以上の収益シェアを占め、世界の薬局業界を支配しました。これは、この地域で事業を展開する様々な製薬会社と、特に米国で複数の場所にサービスを提供する大規模な小売薬局チェーンによるものです。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 薬局市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 薬局市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 薬局市場：製品推定・動向分析

  • 製品セグメントダッシュボード
  • 薬局市場：製品変動分析
  • 世界の薬局市場規模と動向分析（製品別、2018～2030年）
  • 処方
  • OTC

第5章 薬局市場：タイプ推定・動向分析

  • タイプセグメントダッシュボード
  • 薬局市場：タイプ変動分析
  • 世界の薬局市場規模と動向分析（タイプ別、2018～2030年）
  • 病院薬局
  • 小売薬局
    • チェーン
    • 独立
    • その他
  • 電子薬局
  • その他

第6章 薬局市場：地域推定・動向分析

  • 地域市場ダッシュボード
  • 地域別市場シェア分析、2024年および2030年
  • 地域別連続バイオプロセス市場：主なポイント
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ノルウェー
    • スウェーデン
    • デンマーク
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 企業/競合の分類
  • ベンダー情勢
  • 企業プロファイル
    • CVS Health
    • Boots Walgreens
    • Walmart Inc.
    • The Kroger Co.
    • Rite Aid Corp.
    • MCKESSON CORPORATION
    • Well Pharmacy
    • Humana
    • Matsumotokiyoshi Co., Ltd.
    • Apollo Pharmacy
    • MedPlusMart.com
    • Amazon
図表

List of Tables

  • Table 1 List of abbreviations
  • Table 2 Global pharmacy market, by region, 2018 - 2030 (USD Million)
  • Table 3 Global pharmacy market, by product, 2018 - 2030 (USD Million)
  • Table 4 Global pharmacy market, by type, 2018 - 2030 (USD Million)
  • Table 5 North America pharmacy market, by country, 2018 - 2030 (USD Million)
  • Table 6 North America pharmacy market, by product, 2018 - 2030 (USD Million)
  • Table 7 North America pharmacy market, by type, 2018 - 2030 (USD Million)
  • Table 8 U.S. pharmacy market, by product, 2018 - 2030 (USD Million)
  • Table 9 U.S. pharmacy market, by type, 2018 - 2030 (USD Million)
  • Table 10 Canada pharmacy market, by product, 2018 - 2030 (USD Million)
  • Table 11 Canada pharmacy market, by type, 2018 - 2030 (USD Million)
  • Table 12 Mexico pharmacy market, by product, 2018 - 2030 (USD Million)
  • Table 13 Mexico pharmacy market, by type, 2018 - 2030 (USD Million)
  • Table 14 Europe pharmacy market, by country, 2018 - 2030 (USD Million)
  • Table 15 Europe pharmacy market, by product, 2018 - 2030 (USD Million)
  • Table 16 Europe pharmacy market, by type, 2018 - 2030 (USD Million)
  • Table 17 Germany pharmacy market, by product, 2018 - 2030 (USD Million)
  • Table 18 Germany pharmacy market, by type, 2018 - 2030 (USD Million)
  • Table 19 UK pharmacy market, by product, 2018 - 2030 (USD Million)
  • Table 20 UK pharmacy market, by type, 2018 - 2030 (USD Million)
  • Table 21 France pharmacy market, by product, 2018 - 2030 (USD Million)
  • Table 22 France pharmacy market, by type, 2018 - 2030 (USD Million)
  • Table 23 Italy pharmacy market, by product, 2018 - 2030 (USD Million)
  • Table 24 Italy pharmacy market, by type, 2018 - 2030 (USD Million)
  • Table 25 Spain pharmacy market, by product, 2018 - 2030 (USD Million)
  • Table 26 Spain pharmacy market, by type, 2018 - 2030 (USD Million)
  • Table 27 Denmark pharmacy market, by product, 2018 - 2030 (USD Million)
  • Table 28 Denmark pharmacy market, by type, 2018 - 2030 (USD Million)
  • Table 29 Sweden pharmacy market, by product, 2018 - 2030 (USD Million)
  • Table 30 Sweden pharmacy market, by type, 2018 - 2030 (USD Million)
  • Table 31 Norway pharmacy market, by product, 2018 - 2030 (USD Million)
  • Table 32 Norway pharmacy market, by type, 2018 - 2030 (USD Million)
  • Table 33 Asia Pacific pharmacy market, by country, 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific pharmacy market, by product, 2018 - 2030 (USD Million)
  • Table 35 Asia Pacific pharmacy market, by type, 2018 - 2030 (USD Million)
  • Table 36 China pharmacy market, by product, 2018 - 2030 (USD Million)
  • Table 37 China pharmacy market, by type, 2018 - 2030 (USD Million)
  • Table 38 Japan pharmacy market, by product, 2018 - 2030 (USD Million)
  • Table 39 Japan pharmacy market, by type, 2018 - 2030 (USD Million)
  • Table 40 India pharmacy market, by product, 2018 - 2030 (USD Million)
  • Table 41 India pharmacy market, by type, 2018 - 2030 (USD Million)
  • Table 42 South Korea pharmacy market, by product, 2018 - 2030 (USD Million)
  • Table 43 South Korea pharmacy market, by type, 2018 - 2030 (USD Million)
  • Table 44 Australia pharmacy market, by product, 2018 - 2030 (USD Million)
  • Table 45 Australia pharmacy market, by type, 2018 - 2030 (USD Million)
  • Table 46 Thailand pharmacy market, by product, 2018 - 2030 (USD Million)
  • Table 47 Thailand pharmacy market, by type, 2018 - 2030 (USD Million)
  • Table 48 Latin America pharmacy market, by country, 2018 - 2030 (USD Million)
  • Table 49 Latin America pharmacy market, by product, 2018 - 2030 (USD Million)
  • Table 50 Latin America pharmacy market, by type, 2018 - 2030 (USD Million)
  • Table 51 Latin America pharmacy market, by type, 2018 - 2030 (USD Million)
  • Table 52 Brazil pharmacy market, by product, 2018 - 2030 (USD Million)
  • Table 53 Brazil pharmacy market, by type, 2018 - 2030 (USD Million)
  • Table 54 Argentina pharmacy market, by product, 2018 - 2030 (USD Million)
  • Table 55 Argentina pharmacy on market, by type, 2018 - 2030 (USD Million)
  • Table 56 MEA pharmacy market, by region, 2018 - 2030 (USD Million)
  • Table 57 MEA pharmacy market, by product, 2018 - 2030 (USD Million)
  • Table 58 MEA pharmacy market, by type, 2018 - 2030 (USD Million)
  • Table 59 South Africa pharmacy market, by product, 2018 - 2030 (USD Million)
  • Table 60 South Africa pharmacy market, by type, 2018 - 2030 (USD Million)
  • Table 61 Saudi Arabia pharmacy market, by product, 2018 - 2030 (USD Million)
  • Table 62 Saudi Arabia pharmacy market, by type, 2018 - 2030 (USD Million)
  • Table 63 UAE pharmacy market, by product, 2018 - 2030 (USD Million)
  • Table 64 UAE pharmacy market, by type, 2018 - 2030 (USD Million)
  • Table 65 Kuwait pharmacy market, by product, 2018 - 2030 (USD Million)
  • Table 66 Kuwait pharmacy market, by type, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Pharmacy market: Market outlook
  • Fig. 10 Pharmacy competitive insights
  • Fig. 11 Parent market outlook
  • Fig. 12 Related/ancillary market outlook
  • Fig. 13 Penetration and growth prospect mapping
  • Fig. 14 Industry value chain analysis
  • Fig. 15 Pharmacy market driver impact
  • Fig. 16 Pharmacy market restraint impact
  • Fig. 17 Pharmacy market strategic initiatives analysis
  • Fig. 18 Pharmacy market: Product movement analysis
  • Fig. 19 Pharmacy market: Product outlook and key takeaways
  • Fig. 20 Prescription products market estimates and forecast, 2018 - 2030
  • Fig. 21 OTC products market estimates and forecast, 2018 - 2030
  • Fig. 22 Pharmacy market: Type movement Analysis
  • Fig. 23 Pharmacy market: Type outlook and key takeaways
  • Fig. 24 Hospital pharmacy market estimates and forecasts, 2018 - 2030
  • Fig. 25 Retail pharmacy market estimates and forecasts, 2018 - 2030
  • Fig. 26 Chain retail pharmacy market estimates and forecasts, 2018 - 2030
  • Fig. 27 Independent retail pharmacy market estimates and forecasts, 2018 - 2030
  • Fig. 28 Other retail pharmacies market estimates and forecasts, 2018 - 2030
  • Fig. 29 epharmacy market estimates and forecasts, 2018 - 2030
  • Fig. 30 Other pharmacy market estimates and forecasts, 2018 - 2030
  • Fig. 31 Global pharmacy market: Regional movement analysis
  • Fig. 32 Global pharmacy market: Regional outlook and key takeaways
  • Fig. 33 North America market estimates and forecasts, 2018 - 2030
  • Fig. 34 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 35 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 36 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 37 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 38 UK market estimates and forecasts, 2018 - 2030
  • Fig. 39 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 40 France market estimates and forecasts, 2018 - 2030
  • Fig. 41 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 42 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 43 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 44 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 45 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 46 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 47 China market estimates and forecasts, 2018 - 2030
  • Fig. 48 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 49 India market estimates and forecasts, 2018 - 2030
  • Fig. 50 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 51 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 52 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 53 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 54 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 55 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 56 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 57 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 58 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 59 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 60 Kuwait market estimates and forecasts, 2018 - 2030
目次
Product Code: GVR-4-68039-701-1

Pharmacy Market Growth & Trends:

The global pharmacy market size is anticipated to reach USD 2.06 trillion by 2030 and is anticipated to expand at a CAGR of 7.3% during the forecast period, according to a new report by Grand View Research, Inc. The rising prevalence of chronic diseases, increasing market penetration of online pharmacy services, and the entry of global retail companies into this market are primarily driving the growth.

Increasing investments by key market participants in improving presence across various regions, collaborations among companies, and rising adoption of online pharmacy services that offer convenience and cost savings are expected to fuel further growth of this market. The growing incident rate of accidents leading to higher demand for OTC drugs and the growth experienced by the prescription medicine segment, primarily due to enhanced diagnostic technologies and imaging techniques, are likely to develop strong growth opportunities over the forecast period.

Adoption of advanced technologies for enhanced processes and service delivery, availability of various software solutions developed for pharmacy industry participants, and increasing ubiquity of smartphone devices, which facilitates the growth of ePharmacy services, also contribute to the advancements experienced by this market. Collaborations among key companies, the growing digital footprint of online pharmacies, and the focus of numerous key market participants on enhancing global presence also influence this market.

Pharmacy Market Report Highlights:

  • On the basis of products, the prescription segment dominated the global pharmacy industry and accounted for over 80% of the revenue share in 2024, owing to the rising occurrence of chronic illnesses such as cancer, diabetes, and cardiovascular diseases.
  • The OTC segment is projected to experience the fastest growth over the forecast period.
  • The retail pharmacy segment held the largest revenue share of the pharmacy industry, owing to the entry of multiple global retail companies in the pharmacy business, a vast network of retail pharmacy stores operated by key players, and the growth experienced by online retail pharmacy.
  • The ePharmacy segment is anticipated to experience the fastest growth over the forecast period.
  • North America dominated the global pharmacy industry with a revenue share of more than 50% in 2024, owing to various pharmaceutical manufacturing companies operating in the region and large retail pharmacy chains providing services across multiple locations, especially in the U.S.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product segment
    • 1.2.2. Type segment
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Type outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Pharmacy Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Pharmacy Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis

Chapter 4. Pharmacy Market: Product Estimates & Trend Analysis

  • 4.1. Product Segment Dashboard
  • 4.2. Pharmacy Market: Product Movement Analysis
  • 4.3. Global Pharmacy Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Prescription
    • 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. OTC
    • 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Pharmacy Market: Type Estimates & Trend Analysis

  • 5.1. Type Segment Dashboard
  • 5.2. Pharmacy Market: Type Movement Analysis
  • 5.3. Global Pharmacy Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 5.4. Hospital Pharmacy
    • 5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Retail Pharmacy
    • 5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.2. Chain
      • 5.5.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.3. Independent
      • 5.5.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.4. Others
      • 5.5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. ePharmacy
    • 5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Pharmacy Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Dashboard
  • 6.2. Regional Market Share Analysis, 2024 & 2030
  • 6.3. Continuous bioprocessing market by Region: Key Takeaways
  • 6.4. North America
    • 6.4.1. U.S.
      • 6.4.1.1. Key country dynamics
      • 6.4.1.2. Regulatory framework/ reimbursement structure
      • 6.4.1.3. Competitive scenario
      • 6.4.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.2. Canada
      • 6.4.2.1. Key country dynamics
      • 6.4.2.2. Regulatory framework/ reimbursement structure
      • 6.4.2.3. Competitive scenario
      • 6.4.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.3. Mexico
      • 6.4.3.1. Key country dynamics
      • 6.4.3.2. Regulatory framework/ reimbursement structure
      • 6.4.3.3. Competitive scenario
      • 6.4.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Europe
    • 6.5.1. UK
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework/ reimbursement structure
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.2. Germany
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/ reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.3. France
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework/ reimbursement structure
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.4. Italy
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Regulatory framework/ reimbursement structure
      • 6.5.4.3. Competitive scenario
      • 6.5.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.5. Spain
      • 6.5.5.1. Key country dynamics
      • 6.5.5.2. Regulatory framework/ reimbursement structure
      • 6.5.5.3. Competitive scenario
      • 6.5.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.6. Norway
      • 6.5.6.1. Key country dynamics
      • 6.5.6.2. Regulatory framework/ reimbursement structure
      • 6.5.6.3. Competitive scenario
      • 6.5.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.7. Sweden
      • 6.5.7.1. Key country dynamics
      • 6.5.7.2. Regulatory framework/ reimbursement structure
      • 6.5.7.3. Competitive scenario
      • 6.5.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.8. Denmark
      • 6.5.8.1. Key country dynamics
      • 6.5.8.2. Regulatory framework/ reimbursement structure
      • 6.5.8.3. Competitive scenario
      • 6.5.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Japan
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework/ reimbursement structure
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.2. China
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.3. India
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework/ reimbursement structure
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.4. Australia
      • 6.6.4.1. Key country dynamics
      • 6.6.4.2. Regulatory framework/ reimbursement structure
      • 6.6.4.3. Competitive scenario
      • 6.6.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.5. South Korea
      • 6.6.5.1. Key country dynamics
      • 6.6.5.2. Regulatory framework/ reimbursement structure
      • 6.6.5.3. Competitive scenario
      • 6.6.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.6. Thailand
      • 6.6.6.1. Key country dynamics
      • 6.6.6.2. Regulatory framework/ reimbursement structure
      • 6.6.6.3. Competitive scenario
      • 6.6.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Brazil
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework/ reimbursement structure
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.2. Argentina
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.8. MEA
    • 6.8.1. South Africa
      • 6.8.1.1. Key country dynamics
      • 6.8.1.2. Regulatory framework/ reimbursement structure
      • 6.8.1.3. Competitive scenario
      • 6.8.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.2. Saudi Arabia
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Regulatory framework/ reimbursement structure
      • 6.8.2.3. Competitive scenario
      • 6.8.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.3. UAE
      • 6.8.3.1. Key country dynamics
      • 6.8.3.2. Regulatory framework/ reimbursement structure
      • 6.8.3.3. Competitive scenario
      • 6.8.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.4. Kuwait
      • 6.8.4.1. Key country dynamics
      • 6.8.4.2. Regulatory framework/ reimbursement structure
      • 6.8.4.3. Competitive scenario
      • 6.8.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. Key company heat map analysis, 2024
  • 7.4. Company Profiles
    • 7.4.1. CVS Health
      • 7.4.1.1. Company overview
      • 7.4.1.2. Financial performance
      • 7.4.1.3. Product benchmarking
      • 7.4.1.4. Strategic initiatives
    • 7.4.2. Boots Walgreens
      • 7.4.2.1. Company overview
      • 7.4.2.2. Financial performance
      • 7.4.2.3. Product benchmarking
      • 7.4.2.4. Strategic initiatives
    • 7.4.3. Walmart Inc.
      • 7.4.3.1. Company overview
      • 7.4.3.2. Financial performance
      • 7.4.3.3. Product benchmarking
      • 7.4.3.4. Strategic initiatives
    • 7.4.4. The Kroger Co.
      • 7.4.4.1. Company overview
      • 7.4.4.2. Financial performance
      • 7.4.4.3. Product benchmarking
      • 7.4.4.4. Strategic initiatives
    • 7.4.5. Rite Aid Corp.
      • 7.4.5.1. Company overview
      • 7.4.5.2. Financial performance
      • 7.4.5.3. Product benchmarking
      • 7.4.5.4. Strategic initiatives
    • 7.4.6. MCKESSON CORPORATION
      • 7.4.6.1. Company overview
      • 7.4.6.2. Financial performance
      • 7.4.6.3. Product benchmarking
      • 7.4.6.4. Strategic initiatives
    • 7.4.7. Well Pharmacy
      • 7.4.7.1. Company overview
      • 7.4.7.2. Financial performance
      • 7.4.7.3. Product benchmarking
      • 7.4.7.4. Strategic initiatives
    • 7.4.8. Humana
      • 7.4.8.1. Company overview
      • 7.4.8.2. Financial performance
      • 7.4.8.3. Product benchmarking
      • 7.4.8.4. Strategic initiatives
    • 7.4.9. Matsumotokiyoshi Co., Ltd.
      • 7.4.9.1. Company overview
      • 7.4.9.2. Financial performance
      • 7.4.9.3. Product benchmarking
      • 7.4.9.4. Strategic initiatives
    • 7.4.10. Apollo Pharmacy
      • 7.4.10.1. Company overview
      • 7.4.10.2. Financial performance
      • 7.4.10.3. Product benchmarking
      • 7.4.10.4. Strategic initiatives
    • 7.4.11. MedPlusMart.com
      • 7.4.11.1. Company overview
      • 7.4.11.2. Financial performance
      • 7.4.11.3. Product benchmarking
      • 7.4.11.4. Strategic initiatives
    • 7.4.12. Amazon
      • 7.4.12.1. Company overview
      • 7.4.12.2. Financial performance
      • 7.4.12.3. Product benchmarking
      • 7.4.12.4. Strategic initiatives